Seung Noh - AnaPass Non-Executive Independent Director
| 123860 Stock | KRW 28,200 3,150 1.62% |
Director
Seung Noh is Non-Executive Independent Director of AnaPass since 2013.
| Age | 49 |
| Tenure | 11 years |
| Phone | (82) 2 6922 7462 |
| Web | www.anapass.com/ |
AnaPass Management Efficiency
The company has return on total asset (ROA) of (0.0194) % which means that it has lost $0.0194 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 9.2093 %, meaning that it generated $9.2093 on every $100 dollars invested by stockholders. AnaPass' management efficiency ratios could be used to measure how well AnaPass manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 319.13 M in total debt with debt to equity ratio (D/E) of 18.5, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AnaPass has a current ratio of 2.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist AnaPass until it has trouble settling it off, either with new capital or with free cash flow. So, AnaPass' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AnaPass sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AnaPass to invest in growth at high rates of return. When we think about AnaPass' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 13 records | DIRECTOR Age | ||
| Seong Kang | Aprogen Healthcare Games | 43 | |
| Jin Jung | Aprogen Healthcare Games | 42 | |
| Sun Park | Aprogen Healthcare Games | 48 | |
| YeongJun Song | Daejung Chemicals Metals | 51 | |
| Xinhui Wu | Aprogen Healthcare Games | 35 | |
| Hyeon Gil | Eagle Veterinary Technology | 69 | |
| Gyo Geum | Daejung Chemicals Metals | 45 | |
| Su Yim | Aprogen Healthcare Games | 59 | |
| Wei Zhou | Aprogen Healthcare Games | 35 | |
| Fei Wang | Aprogen Healthcare Games | 39 | |
| Wei Zhao | Aprogen Healthcare Games | 31 | |
| Bong Choi | Ilji Technology Co | 64 | |
| Xiao Li | Aprogen Healthcare Games | 33 | |
Management Performance
| Return On Equity | 9.21 | |||
| Return On Asset | -0.0194 |
AnaPass Leadership Team
Elected by the shareholders, the AnaPass' board of directors comprises two types of representatives: AnaPass inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AnaPass. The board's role is to monitor AnaPass' management team and ensure that shareholders' interests are well served. AnaPass' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AnaPass' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gyeong Lee, CEO, Director | ||
| Seung Noh, Non-Executive Independent Director | ||
| Man Jang, Non-Executive Independent Director | ||
| Kim Paul, Director | ||
| Seong Cho, Director | ||
| Jun Jung, Vice President | ||
| Cheon Kim, Vice President |
AnaPass Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AnaPass a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 9.21 | |||
| Return On Asset | -0.0194 | |||
| Profit Margin | (0.47) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 218.58 B | |||
| Shares Outstanding | 9.98 M | |||
| Shares Owned By Insiders | 23.58 % | |||
| Shares Owned By Institutions | 0.14 % | |||
| Price To Earning | 61.56 X | |||
| Price To Sales | 4.30 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaPass. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AnaPass information on this page should be used as a complementary analysis to other AnaPass' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for AnaPass Stock analysis
When running AnaPass' price analysis, check to measure AnaPass' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaPass is operating at the current time. Most of AnaPass' value examination focuses on studying past and present price action to predict the probability of AnaPass' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaPass' price. Additionally, you may evaluate how the addition of AnaPass to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |